Prognostic value of total tumor volume in advanced-stage laryngeal and hypopharyngeal carcinoma.
To evaluate the prognostic value of total tumor volume (TTV) in patients with laryngeal and hypopharyngeal carcinomas. This study involved 182 patients with previously untreated advanced-stage squamous cell carcinoma of the larynx or hypopharynx. TTV were calculated from pretreatment contrast-enhanced computed tomography images. Univariate and multivariate analyses were used to identify factors associated with overall (OS), disease-specific (DSS), and disease-free survival (DFS). At a median follow-up of 63 months (range, 24-139 months), the 5 year OS, DSS, and DFS rates were 60.2%, 73.1%, and 69.4%, respectively. Multivariate analyses showed that tumor site was an independent predictor of DSS (P = 0.03); Charlson comorbidity index for OS (P = 0.001); second primary cancer for OS (P = 0.008) and DFS (P = 0.001); and vocal fold paralysis for DSS (P = 0.014) and DFS (P = 0.033). Extension to the tongue base was an independent predictor of OS (P = 0.007), DSS (P < 0.001), and DFS (P = 0.017), and TTV ≥8.38 ml was an independent predictor of all three survivals (P < 0.001 each). Radiologically determined TTV is prognostic of survival in patients with advanced-stage laryngeal and hypopharyngeal carcinoma.